Loop Capital raised the firm’s price target on American Vanguard to $20 from $19 and keeps a Buy rating on the shares. The firm sees the company benefiting from the ongoing AgChem industry’s fundamental inflection, the emerging business process re-engineering effort at American Vanguard, and the collective effort by American Vanguard to demonstrate commercial traction and growth, with novel Ag productivity and/or sustainability-oriented platforms that include Biologics, Envance Technologies, and the precision planting concept, SIMPAS, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>